Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FVK07
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,533
Award facts
- Contract value 100% obligated
- $17,532.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL) valued at $17,532.61. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by April 23, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order as a child contract under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical.
This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's comprehensive $999,999,999.00 IDC vehicle (SPE2DX) with the Defense Logistics Agency, which extends through December 2026. The IDC serves as a global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The Ozempic procurement falls within DLA's medical supply chain operations, supporting federal healthcare systems including the Defense Health Agency and other government entities that rely on AmerisourceBergen's extensive portfolio of brand-name and generic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FVK07?
SPE2DB25FVK07 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 22, 2025.
How much is contract SPE2DB25FVK07 worth?
The government has obligated $17,533 on SPE2DB25FVK07.
Is contract SPE2DB25FVK07 an order under another contract?
Yes. SPE2DB25FVK07 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FVK07 competed?
The extent of competition for SPE2DB25FVK07 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award